-
Mashup Score: 36
This randomized clinical trial examines whether adding chemotherapy with pemetrexed and carboplatin to gefitinib improves survival among patients with epidermal growth factor receptor (EGFR)–variant non–small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
This report describes the development of an 18-gene urine panel for high-grade prostate cancer and validates its external performance relative to current guideline-endorsed biomarkers.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 127Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy - 2 day(s) ago
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17
This nonrandomized controlled trial investigates the acute toxic effects of treatment with hypofractionated pelvic intensity-modulated radiotherapy and concurrent chemotherapy among women who experienced lymph node metastasis, parametrial invasion, or positive resection margins after radical…
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 49Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma - 4 day(s) ago
This randomized clinical trial examines if radiotherapy is noninferior to chemoradiotherapy after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21
This clinical trial examines the safety, efficacy, and biosimilarity of MW032 compared with denosumab in patients with solid tumor–related bone metastases.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 92Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer - 6 day(s) ago
This case series assesses overall and progression-free survival and safety outcomes of chemotherapy and immunotherapy combination treatment in patients 75 years and older with non–small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 22
This cohort study examines the risk of a second primary breast cancer in women who were aged 40 years or younger when first diagnosed with breast cancer.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Policy Priorities in Cancer Care for Transgender People - 7 day(s) ago
This Viewpoint calls for health care systems, oncologists, and staff to prioritize and adopt policies that are inclusive and respectful of transgender patients with cancer.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
This case series reports durable remissions in 2 patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with allogeneic bispecific CD19/CD22-targeting chimeric antigen receptor T cells.
Source: jamanetwork.comCategories: General Medicine News, Onc News and JournalsTweet
Progression-free survival and overall survival benefits of adding chemotherapy to gefitinib were sustained at 5 years, confirming earlier results reported at median follow-up of 17 months. https://t.co/T1v8xcXD2V https://t.co/0ralMMKMkZ